A survey on the quality of care among patients with heart failure in Europe

European Journal of Heart Failure

Volumn 2, Issue 2, 2000, Pages 123-132

  Cleland, J G F ^a   Swedberg, K ^b   Cohen Solal, A ^b   Cosin Aguilar, J ^b   Dietz, R ^b   Follath, F ^b   Gavazzi, A ^b   Hobbs, R ^c   Korewicki, J ^b   Madeira, H C ^b   Preda, I ^b   Van Gilst, W H ^b   Widimsky, J ^b   Mareev, V ^b   Mason, J ^d   Freemantle, N ^d   Eastaugh, Joanne ^d  

^a NONE   (United Kingdom)

^b NONE   (Russian Federation)

^c Innovation Birmingham   (United Kingdom)

^d York   (United Kingdom)

Author keywords

Euroheart; Heart failure; Survey

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; EUROPE; HEALTH CARE QUALITY; HEALTH SURVEY; HEART LEFT VENTRICLE FUNCTION; HUMAN; MULTICENTER STUDY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; HEART FAILURE; HOSPITAL DISCHARGE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; EUROPE; HEALTH SURVEYS; HEART FAILURE, CONGESTIVE; HUMANS; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034200822     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1388-9842(00)00081-7     Document Type: Article

References (35)

1. Cleland J.G.F., Erdmann E., Ferrari R., Hess O.M., Poole Wilson P.A., Remme W.J. et al. Guidelines for the diagnosis of heart failure. Eur Heart J. 16:1995;741-751.
2. The treatment of heart failure. Eur Heart J. 18:1997;736-753.
3. Cleland J.G.F. ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'? J Hum Hypertens. 9:1995;435-442.
4. Hillis G.S., Trent R.J., Winton P., MacLeod A., Jennings K.P. Angiotensin-converting enzyme inhibitors: are we ignoring the evidence? Q J Med. 89:1996;145-150.
5. Philbin E.F., Andreou C., Rocco T.A., Lynch L.J., Baker S.L. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 77:1996;832-838.
6. Mair F.S., Crowley T.S., Bundred P.E. Prevalence, aetiology and management of heart failure in general practice. Br Gen Pract. 46:1996;77-79.
7. Hillis G.S., Al-Mohammad A., Wood M., Jennings K.P. Changing patterns of investigation and treatment of cardiac failure in hospital. Heart. 76:1996;427-429.
8. Philbin E.F. Factors determining angiotensin-converting enzyme inhibitor underutilisation in heart failure in a community setting. Clin Cardiol. 21:1998;103-108.
9. Clarke K.W., Gray D., Hampton J.R. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 71:1994;584-587.
10. Cowie M.R., Wood D.A., Coats A.J.S., Thompson S.G., Poole-Wilson P.A., Suresh V. et al. Incidence and aetiology of heart failure: a population based study. Eur Heart J. 20:1999;421-428.
11. McMurray J.M., McDonagh T., Morrison C.E., Dargie H.J. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J. 14:1993;1158-1162.
12. Cleland J.G.F., Gemmel I., Khand A., Boddy A. Is the prognosis of heart failure improving? Eur J Heart Failure. 1:1999;229-241.
13. Brown A., Cleland J.G.F. Influence of concomitant disease on patterns of hospitalisation in patients with heart failure discharged from Scottish hospitals in 1995. Eur Heart J. 19:1998;1063-1069.
14. Rich M.W., Beckham V., Wittenberg C., Leven C.L., Freedland K.E., Carney R.M. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 333:1995;1190-1195.
15. Cleland J.G.F., Swedberg K., Poole-Wilson P.A. Successes and failures of current treatment of heart failure. Lancet. 352:1998;st19-st28.
16. Increasing the awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative. Eur J Heart Failure. 1:1999;139-144.
17. Cowie M.R., Mosterd A., Wood D.A., Deckers J.W., Poole-Wilson P.A., Sutton G.C. et al. The epidemiology of heart failure. Eur Heart J. 18:1997;208-223.
18. Cleland J.G.F. Screening for left ventricular dysfunction and heart failure: should it be done and if so how? Dis Manage Health Outcomes. 1:1997;169-184.
19. Rogers W.J., Johnstone D.E., Yusuf S., Weiner D.H., Gallagher P., Bittner V.A. et al. Quality of life among 5025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. J Am Coll Cardiol. 23:1994;393-400.
20. Cleland J.G.F. Health economic consequences of the pharmacological treatment of heart failure. Eur Heart J. 19:1998;32-39.
21. Reitsma J.B., Mosterd A., De Craen A.J.M., Koster R.W., van Cappelle F.J.L., Grobbee D.E. et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993. Heart. 76:1996;388-392.
22. Mosterd A., Deckers J.W., Hoes A.W., Nederpel A., Smeets A., Linker D.T. et al. Classification of heart failure in population based research: An assessment of six heart failure scores. Eur J Epidemiol. 13:1997;491-502.
23. McDonagh TA, Robb SD, Morrison CE, Morton JJ, Tunstall-Pedoe H, McMurray JJ, et al. Natriuretic peptides as screening tools for left ventricular dysfunction. Eur Heart J 1996;17:(abs. suppl)317 Abstract.
24. Wallen T., Landahl S., Hedner T., Hall C. Atrialpeptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population. Eur Heart J. 14:1993;1508-1513.
25. Cowie M.R., Struthers A.D., Wood D.A., Coats A.J.S., Thompson S.G., Poole-Wilson P.A. et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1998;1347-1351.
26. Vaz F.G., Seymour D.G. A propsective study of elderly general surgical patients:I. Pre-operative medical problems. Age Ageing. 18:1989;309-315.
27. Wheeldon N.M., MacDonald T.M., Flucker C.J., McKendrlck A.D., McDevitt D.G., Struthers A.D. Echocardiography in chronic heart failure in the community. Q J Med. 86:1993;17-23.
28. Remes J., Miettinen H., Reunanen A., Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 12:1991;315-321.
29. Remes J., Lansimies E., Pyorala K. Usefulness of M-mode echocardiography in the diagnosis of heart failure. Cardiology. 78:1991;267-277.
30. Andersson B., Caidahl K., Waagstein F. An echocardiographic evaluation of patients with idiopathic heart failure. Chest. 107(3):1995;680-689.
31. Ghali J.K., Kadakia S., Cooper R.S., Liao Y.L. Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure. Am J Cardiol. 67(11):1991;1002-1006.
32. Brookes C.I.O., Hart P., Keogh B.E., Cleland J.G.F. Angiography and the aetiology of heart failure. Postgrad Med J. 71:1995;480-482.
33. Sutton G.C. Epidemiologic aspects of heart failure. Am Heart J. 120:1990;1538-1540.
34. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:1999;709-717.
35. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Avorn J. et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 154:1994;433-437.